Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C100H132N26O13 |
| Molecular Weight | 1906.2845 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 14 / 14 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC2=CNC3=C2C=CC=C3)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC4=CNC5=C4C=CC=C5)C(=O)N6CCC[C@H]6C(=O)N[C@H](CC7=CNC8=C7C=CC=C8)C(=O)N[C@@H](CC9=CNC%10=C9C=CC=C%10)C(=O)N%11CCC[C@H]%11C(=O)N[C@@H](CC%12=CNC%13=C%12C=CC=C%13)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(N)=O
InChI
InChIKey=USSYUMHVHQSYNA-PYODXXEMSA-N
InChI=1S/C100H132N26O13/c1-5-57(4)85(102)95(136)123-79(45-56(2)3)96(137)124-42-20-36-82(124)92(133)118-76(46-58-51-110-68-28-11-6-23-63(58)68)89(130)116-74(33-16-17-39-101)88(129)121-80(49-61-54-113-71-31-14-9-26-66(61)71)97(138)125-43-21-38-84(125)94(135)120-78(48-60-53-112-70-30-13-8-25-65(60)70)91(132)122-81(50-62-55-114-72-32-15-10-27-67(62)72)98(139)126-44-22-37-83(126)93(134)119-77(47-59-52-111-69-29-12-7-24-64(59)69)90(131)117-75(35-19-41-109-100(106)107)87(128)115-73(86(103)127)34-18-40-108-99(104)105/h6-15,23-32,51-57,73-85,110-114H,5,16-22,33-50,101-102H2,1-4H3,(H2,103,127)(H,115,128)(H,116,130)(H,117,131)(H,118,133)(H,119,134)(H,120,135)(H,121,129)(H,122,132)(H,123,136)(H4,104,105,108)(H4,106,107,109)/t57-,73-,74-,75-,76-,77-,78+,79-,80-,81-,82-,83-,84-,85-/m0/s1
| Molecular Formula | C100H132N26O13 |
| Molecular Weight | 1906.2845 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 14 / 14 |
| E/Z Centers | 2 |
| Optical Activity | UNSPECIFIED |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| In-vitro activity of lytic peptides alone and in combination with macrolides and inhibitors of dihydrofolate reductase against Pneumocystis carinii. | 1998 Oct |
|
| In vitro anticryptosporidial activity of ranalexin alone and in combination with other peptides and with hydrophobic antibiotics. | 1999 Nov |
|
| Antimicrobial activity of polycationic peptides. | 1999 Nov |
|
| Structural features and biological activities of the cathelicidin-derived antimicrobial peptides. | 2000 |
|
| Activity of nitazoxanide alone and in combination with azithromycin and rifabutin against Cryptosporidium parvum in cell culture. | 2000 Apr |
|
| Fungicidal activity of five cathelicidin peptides against clinically isolated yeasts. | 2006 Nov |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 09:38:50 GMT 2023
by
admin
on
Sat Dec 16 09:38:50 GMT 2023
|
| Record UNII |
073SBV429N
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
90478486
Created by
admin on Sat Dec 16 09:38:50 GMT 2023 , Edited by admin on Sat Dec 16 09:38:50 GMT 2023
|
PRIMARY | |||
|
m6276
Created by
admin on Sat Dec 16 09:38:50 GMT 2023 , Edited by admin on Sat Dec 16 09:38:50 GMT 2023
|
PRIMARY | Merck Index | ||
|
Indolicidin
Created by
admin on Sat Dec 16 09:38:50 GMT 2023 , Edited by admin on Sat Dec 16 09:38:50 GMT 2023
|
PRIMARY | |||
|
140896-21-5
Created by
admin on Sat Dec 16 09:38:50 GMT 2023 , Edited by admin on Sat Dec 16 09:38:50 GMT 2023
|
PRIMARY | |||
|
073SBV429N
Created by
admin on Sat Dec 16 09:38:50 GMT 2023 , Edited by admin on Sat Dec 16 09:38:50 GMT 2023
|
PRIMARY |